Suchergebnisse - "3DRR0X4728"

PubPharm (94)

1

Comparison of efficacy between clazosentan and fasudil hydrochloride-based management of vasospasm after subarachnoid hemorrhage focusing on older and WFNS grade V patients : a single-center experience in Japan

enthalten in: Neurosurgical review | 2024

von Mochizuki, T. | Ryu, B. | Shima, S. | +10

2

Factors Influencing Discontinuation of Clazosentan Therapy in Elderly Patients with Aneurysmal Subarachnoid Hemorrhage : A Retrospective Study from a Japanese Single Center

enthalten in: Medical science monitor : international medical journal of experimental and clinical research | 2024

von Mutoh, T. | Aono, H. | Seto, W. | +4

3

Cardiopulmonary Events of the Elderly (≥75 Years) during Clazosentan Therapy after Subarachnoid Hemorrhage : A Retrospective Study from a Tertiary Stroke Center in Japan

enthalten in: Medicina (Kaunas, Lithuania) | 2024

von Mutoh, T. | Aono, H. | Seto, W. | +4

4

Efficacy and Safety of Clazosentan After Aneurysmal Subarachnoid Hemorrhage : An Updated Meta-Analysis

enthalten in: Neurosurgery | 2023

von Pontes, J. | Santos, M. | Gibram, F. | +4

5

Real-world data of clazosentan in combination therapy for aneurysmal subarachnoid hemorrhage : a multicenter retrospective cohort study

enthalten in: Neurosurgical review | 2023

von Muraoka, S. | Asai, T. | Fukui, T. | +6

6

Letter to the Editor. Clazosentan was superior to placebo, but was the comparison appropriate?

enthalten in: Journal of neurosurgery | 2023

von Kimura, T.

CommentOn: J Neurosurg. 2022 Oct 28;138(5):1254-1262. - PMID 36308478

7

Letter : Clinical Benefit of Clazosentan in Vasospasm After Subarachnoid Hemorrhage: Are We There Yet?

enthalten in: Neurosurgery | 2023

von Katiyar, V. | Kale, A. | Sharma, R. | +2

8

The REACT study : design of a randomized phase 3 trial to assess the efficacy and safety of clazosentan for preventing deterioration due to delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage

enthalten in: BMC neurology | 2022

von Bruder, N. | Higashida, R. | Santin-Janin, H. | +5

9

Effects of clazosentan on cerebral vasospasm-related morbidity and all-cause mortality after aneurysmal subarachnoid hemorrhage : two randomized phase 3 trials in Japanese patients

enthalten in: Journal of neurosurgery | 2022

von Endo, H. | Hagihara, Y. | Kimura, N. | +4

10

Clazosentan : First Approval

enthalten in: Drugs | 2022

von Lee, A.

1
2
3
4
5
6
7
8
9
10
Nächster »
[10]